A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy A Classic Single-Gene Disorder

被引:47
|
作者
Li, Lili
Bainbridge, Matthew Neil
Tan, Yanli
Willerson, James T.
Marian, Ali J. [1 ,2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Inst Mol Med, Ctr Cardiovasc Genet, 6770 Bertner St,Suite C900A, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, Dept Med, 6770 Bertner St,Suite C900A, Houston, TX 77030 USA
[3] Texas Heart Inst, 6770 Bertner St,Suite C900A, Houston, TX 77025 USA
基金
美国国家卫生研究院;
关键词
bioinformatics; cardiomyopathy; echocardiography; exome; genetic testing; siblings; HUMAN HEART; MUTATIONS; COMPOUND; POLYMORPHISM; VARIANTS; RECEPTOR;
D O I
10.1161/CIRCRESAHA.116.310559
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Hypertrophic cardiomyopathy (HCM) is a prototypic single-gene disease caused mainly by mutations in genes encoding sarcomere proteins. Despite the remarkable advances, the causal genes in approximate to 40% of the HCM cases remain unknown, typically in small families and sporadic cases, wherein cosegregation could not be established. Objective: To test the hypothesis that the missing causal genes in HCM is, in part, because of an oligogenic cause, wherein the pathogenic variants do not cosegregate with the phenotype. Methods and Results: A clinically affected trio with HCM underwent clinical evaluation, electrocardiography, echocardiography, magnetic resonance imaging, and whole exome sequencing. Pathogenic variants in the whole exome sequencing data were identified using established algorithms. Family members were genotyped by Sanger sequencing and cosegregation was analyzed. The siblings had a severe course, whereas the mother had a mild course. Variant analysis showed that the trio shared 145 heterozygous pathogenic variants in 139 genes, including 2 in cardiomyopathy genes TTN and ALPK3. The siblings also had the pathogenic variant p. Ala13Thr variant in MYL2, a known gene for HCM. The sibling(s father also carried the p. Ala13Thr variant, in whom an unambiguous diagnosis of HCM could not be made because of concomitant severe aortic stenosis. The TTN variant segregated with HCM, except in a 7-year-old boy, who had a normal phenotype. The ALPK3 variant, shared by the affected trio, did not segregate with the phenotype. Conclusions: We posit that a subset of HCM might be oligogenic caused by multiple pathogenic variants that do not perfectly cosegregate with the phenotype.
引用
收藏
页码:1084 / +
页数:14
相关论文
共 36 条
  • [21] New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy
    Cristina Alonso-Montes
    Manuel Naves-Diaz
    Jose Luis Fernandez-Martin
    Julian Rodriguez-Reguero
    Cesar Moris
    Eliecer Coto
    Jorge B. Cannata-Andia
    Isabel Rodriguez
    [J]. Molecular Biology Reports, 2012, 39 : 8777 - 8785
  • [22] Renin-angiotensin system gene polymorphisms as potential modifiers of hypertrophic and dilated cardiomyopathy phenotypes
    Rani, Bindu
    Kumar, Amit
    Bahl, Ajay
    Sharma, Rajni
    Prasad, Rishikesh
    Khullar, Madhu
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 2017, 427 (1-2) : 1 - 11
  • [23] New polymorphisms in human MEF2C gene as potential modifier of hypertrophic cardiomyopathy
    Alonso-Montes, Cristina
    Naves-Diaz, Manuel
    Luis Fernandez-Martin, Jose
    Rodriguez-Reguero, Julian
    Moris, Cesar
    Coto, Eliecer
    Cannata-Andia, Jorge B.
    Rodriguez, Isabel
    [J]. MOLECULAR BIOLOGY REPORTS, 2012, 39 (09) : 8777 - 8785
  • [24] Single-strand conformation polymorphism analysis on the δ-sarcoglycan gene in Japanese patients with hypertrophic cardiomyopathy
    Date, M
    Otsu, K
    Nishida, K
    Toyofuku, T
    Matsumura, Y
    Morita, T
    Hirotani, S
    Okazaki, Y
    Hayashizaki, Y
    Nigro, V
    Kuzuya, T
    Tada, M
    Hori, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (11): : 1315 - 1318
  • [25] Comparison of Nonclassic and Classic Phenotype of Hypertrophic Cardiomyopathy Focused on Prognostic Cardiac Magnetic Resonance Parameters: A Single-Center Observational Study
    Stachera, Magdalena
    Przybylo, Pawel
    Sznajder, Katarzyna
    Gierlotka, Marek
    [J]. DIAGNOSTICS, 2022, 12 (05)
  • [26] Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy
    de Almeida, Rita Mendes
    Tavares, Joana
    Martins, Sandra
    Carvalho, Teresa
    Enguita, Francisco J.
    Brito, Dulce
    Carmo-Fonseca, Maria
    Lopes, Luis Rocha
    [J]. PLOS ONE, 2017, 12 (08):
  • [27] TROPHECTODERM BIOPSY FOR SINGLE-GENE DISORDER PREIMPLANTATION GENETIC DIAGNOSIS (PGD) IS SIGNIFICANTLY MORE RELIABLE THAN DAY 3 BLASTOMERE BIOPSY
    Forman, E. J.
    Ferry, K. M.
    Gueye, N-A
    Smith, R. D.
    Stevens, J.
    Scott, R. T., Jr.
    [J]. FERTILITY AND STERILITY, 2011, 96 (03) : S222 - S222
  • [28] Pilot study of a novel multi-functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single-gene disorder screening
    Luo, Yuqin
    Jia, Bei
    Yan, Kai
    Liu, Siping
    Song, Xiaojie
    Chen, Mingfa
    Jin, Fan
    Du, Yang
    Wang, Juan
    Hong, Yan
    Cao, Sha
    Li, Dawei
    Dong, Minyue
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2019, 7 (04):
  • [29] Severe Hypertrophic Cardiomyopathy in an Infant with a Novel PRKAG2 Gene Mutation: Potential Differences Between Infantile and Adult Onset Presentation
    Kelly, Brendan P.
    Russell, Mark W.
    Hennessy, James R.
    Ensing, Gregory J.
    [J]. PEDIATRIC CARDIOLOGY, 2009, 30 (08) : 1176 - 1179
  • [30] Severe Hypertrophic Cardiomyopathy in an Infant with a Novel PRKAG2 Gene Mutation: Potential Differences Between Infantile and Adult Onset Presentation
    Brendan P. Kelly
    Mark W. Russell
    James R. Hennessy
    Gregory J. Ensing
    [J]. Pediatric Cardiology, 2009, 30 : 1176 - 1179